Global Coagulation Testing Market to Reach $3.8 Billion by 2027 - ResearchAndMarkets.com

12 Dec 2022
www.businesswire.com
DUBLIN--(BUSINESS WIRE)--The "Coagulation Testing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Coagulation Testing Market to Reach $3.8 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Coagulation Testing estimated at US$2.7 Billion in the year 2020, is projected to reach a revised size of US$3.8 Billion by 2027, growing at a CAGR of 4.8% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 5.1% CAGR and reach US$3.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 3.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $742.5 Million, While China is Forecast to Grow at 7.2% CAGR
The Coagulation Testing market in the U.S. is estimated at US$742.5 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$778.1 Million by the year 2027 trailing a CAGR of 7.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 4.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.
Select Competitors (Total 38 Featured) -
F. Hoffmann-La Roche AG
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/82myiu
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.